LIFECORE BIOMEDICAL, INC. \DE\ LFCR on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001005286
0001005286
EIN:
94-3025618
94-3025618
LEI:
(CF Office: 03 Life Sciences)
Business address:
3515 LYMAN BOULEVARD, CHASKA, MN, 55318
Phone: 9523684300
3515 LYMAN BOULEVARD, CHASKA, MN, 55318
Phone: 9523684300
Mailing address:
3515 LYMAN BOULEVARD, CHASKA, MN, 55318
3515 LYMAN BOULEVARD, CHASKA, MN, 55318
Category:
Accelerated filer
Smaller reporting company
Accelerated filer
Smaller reporting company
Former names:
- LANDEC CORP \CA\ - filings through 2022-11-07
Filings:
1,663 EDGAR filings since February 13, 1996
1,663 EDGAR filings since February 13, 1996
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- February 27, 2025 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 5, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 21, 2025 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- January 17, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- January 7, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- January 2, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- January 2, 2025 - 10-Q: Quarterly report for quarter ending November 24, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- October 4, 2024 - 10-Q: Quarterly report for quarter ending August 25, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 26, 2024 - 10-K: Annual report for year ending May 26, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 12, 2024 - NT 10-K: Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Open documentClick to Open document FilingOpen filingClick to Open filing
- August 9, 2024 - 10-Q: Quarterly report for quarter ending February 25, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 9, 2024 - 10-Q: Quarterly report for quarter ending November 26, 2023Open documentClick to Open document FilingOpen filingClick to Open filing
- August 9, 2024 - 10-Q: Quarterly report for quarter ending August 27, 2023Open documentClick to Open document FilingOpen filingClick to Open filing
- April 8, 2024 - NT 10-Q: Notification of inability to timely file Form 10-Q or 10-QSB Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- February 27, 2025 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- January 21, 2025 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- September 23, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- January 8, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- December 10, 2024 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- December 10, 2024 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 5, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
Form type | Form description | Filing date | Reporting date |
---|
0
Showing 1 to 25 of 1,000 entries
Data source:
CIK0001005286.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors